Drug-induced, factitious, & idiopathic diarrhoea
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 26 (5) , 633-648
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Adverse drug reactions to anthroposophic and homeopathic solutions for injection: a systematic evaluation of German pharmacovigilance databasesPharmacoepidemiology and Drug Safety, 2012
- Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tractLife Sciences, 2010
- Class I antiarrhythmics inhibit Na+ absorption and Cl− secretion in rabbit descending colon epitheliumNaunyn-Schmiedeberg's Archives of Pharmacology, 2005
- Comparative Analysis of the in Vitro Prosecretory Effects of Balsalazide, Sulfasalazine, Olsalazine, and Mesalamine in Rabbit Distal IleumInflammatory Bowel Diseases, 2005
- Tolerance of Probiotics and PrebioticsJournal of Clinical Gastroenterology, 2004
- Drug-Induced DiarrhoeaDrug Safety, 2000
- Mechanisms of Drug-Induced Diarrhoea in the ElderlyDrugs & Aging, 1998
- Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitusThe American Journal of Medicine, 1995
- A Risk-Benefit Appraisal of Acarbose in the Management of Non-Insulin-Dependent Diabetes MellitusDrug Safety, 1994
- ACUTE DIARRHOEA IN THE ELDERLYAge and Ageing, 1980